AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglow 0.3 GM2 Tablet

Prescription Icon
Prescription Required

Marketer

Primus Remedies Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglow 0.3 GM2 Tablet

DiaBeta-0.3 MG2 tablets are classified as antidiabetic medications, specifically a combination therapy for adult-onset type 2 diabetes. This medication helps regulate blood glucose levels. DiaBeta-0.3 MG2 tablets should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with seemingly controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is a component of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Prompt recognition and treatment are essential. Maintain regular mealtimes and carry readily available glucose sources, such as sugary snacks or fruit juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Voglow 0.3 GM2 Tablet

No text provided to rephrase.

Uses of Voglow 0.3 GM2 Tablet

Managing type 2 diabetes

Major Benefits of Voglow 0.3 GM2 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 0.3 GM2 Voglow tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

Common Side effects of Voglow 0.3 GM2 Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglow 0.3 GM2 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Voglow 0.3 GM2 Tablets should be taken on an empty stomach.

How Voglow 0.3 GM2 Tablet works:

Tri-action Voglow 0.3 GM2 tablets contain a blend of three antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglow 0.3 GM2 Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Voglow 0.3 GM2 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding mothers should likely avoid Voglow 0.3 GM2 Tablets. Available evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Voglow 0.3 GM2 Tablets due to potential safety concerns. A physician's consultation is advised. Furthermore, Voglow 0.3 GM2 Tablets are contraindicated for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Voglow 0.3 GM2 Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate hepatic dysfunction, initiating therapy with a reduced dose of Voglow 0.3 GM2 Tablets is typical; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Voglow 0.3 GM2 Tablet :

Should you forget a Voglow 0.3 GM2 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglow 0.3 GM2 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Voglow 0.3 GM2 Tablet

Voglow 0.3 GM2 Tablet combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-drug therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Voglow 0.3 GM2 Tablet may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, rash, and respiratory infection.
Voglow 0.3 GM2 Tablets are contraindicated in patients with known allergies to any ingredient, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Voglow 0.3 GM2 Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglow 0.3 GM2 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Voglow 0.3 GM2 Tablet
108
MRP 132
18% off